Friday, July 1, 2022

Siam Bioscience

Penghantaran bekalan AstraZeneca untuk Asia Tenggara kini sedia

Siam Bioscience Co Ltd yang mengeluarkan AstraZeneca di Thailand akan menghasilkan kira-kira 180 juta dos tahun ini.

Thai-made AstraZeneca vaccines causing delays across Southeast Asia

Questions about Siam Bioscience meeting production targets are sensitive because King Maha Vajiralongkorn is its sole owner.

Thai court orders removal of clips claiming king’s company ‘favoured’ in Covid-19 vaccine manufacture

Siam Bioscience is owned by King Maha Vajiralongkorn, and will supply the majority of doses despite an alleged lack of vaccine experience.

Other News